None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) 20 = age < 80 2) American Society of Anesthesiologists physical status of I or II 3) Patients who voluntarily consented in writing to participate in this clinical trial
Exclusion criteria
Exclusion criteria: 1) Patients with neuromuscular disease, liver disease, or kidney disease 2) Patients taking medications that affect neuromuscular function 3) Patients taking magnesium 4) pregnancy 5) If the patient does not consent to participate in the study 6) Patients undergoing emergency surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time from the time of injection of muscle relaxant until T1 appears again after reaching T0 | — |
Secondary
| Measure | Time frame |
|---|---|
| Time from the time of injection of muscle relaxant until T1 appears again after reaching T0 ;Specific events from induction of anesthesia to termination of anesthesia | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center